Clinical Trials Directory

Trials / Completed

CompletedNCT00058903

Treatment of Cholestatic Pruritus With Sertraline

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · NIH
Sex
All
Age
21 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The goal of this study is to find an effective and well-tolerated medical therapy for itching due to liver disease. Persons with primary biliary cirrhosis or chronic hepatitis C are currently being enrolled in the study. Persons participating in the study are given sertraline, a medication which is also often used for depression,to treat their itching. The dose is gradually increased as the effect on itching and any other potential side effects are carefully monitored.

Conditions

Interventions

TypeNameDescription
DRUGsertraline

Timeline

Start date
2003-04-01
Completion
2005-03-01
First posted
2003-04-16
Last updated
2010-01-13

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00058903. Inclusion in this directory is not an endorsement.